No items found.
Article
View in PDF Format
Prevalence predictions for age-related macular degeneration in New Zealand have implications for provision of healthcare services
Open Access
View Article PDF
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
For the PDF of this article,
contact nzmj@nzma.org.nz
Article
View in PDF Format
Prevalence predictions for age-related macular degeneration in New Zealand have implications for provision of healthcare services
View Article PDF
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
For the PDF of this article,
contact nzmj@nzma.org.nz
Article
View in PDF Format
Prevalence predictions for age-related macular degeneration in New Zealand have implications for provision of healthcare services
View Article PDF
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
Contact diana@nzma.org.nz
for the PDF of this article
Article
View in PDF Format
Prevalence predictions for age-related macular degeneration in New Zealand have implications for provision of healthcare services
View Article PDF
Summary
Abstract
Aim
Method
Results
Conclusion
Author Information
Acknowledgements
Correspondence
Correspondence Email
Competing Interests
Contact diana@nzma.org.nz
for the PDF of this article
Prevalence predictions for age-related macular degeneration in New Zealand have implications for provision of healthcare services
Age-related macular degeneration (AMD) is the leading cause of visual loss in individuals older than 50 years in New Zealand, as it is for the developed world as a whole.
Subscriber Content
The full contents of this pages only available to subscribers.
Login, subscribe or email nzmj@nzma.org.nz to purchase this article.
No items found.
